SCHEMBL1660045

SCHEMBL1660045

O=[C]c1coc(Oc2cccc(C3CCCC3)c2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
KMO O15229 1/20 0.35
HTR2C P28335 2/20 0.35
TAAR1 Q96RJ0 1/20 0.33
DRD2 P14416 3/20 0.32
CETP P11597 1/20 0.31
SPHK1 Q9NYA1 1/20 0.31
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
DRD3 P35462 1/20 0.31
PPARG P37231 3/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31
PRMT5 O14744 1/20 0.30
WDR77 Q9BQA1 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA1D P25100 1/20 0.30
ADRA1A P35348 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660451 0.95 HTR2C (0.36) HTR2CTAAR1DRD2HTR1AADRA1D
SCHEMBL2865183 0.80 KMO (0.46) HDAC4HDAC2HDAC8KMOHTR2C
SCHEMBL2638262 0.77 KMO (0.43) HDAC4HDAC2HDAC8KMOHTR2C
SCHEMBL1659045 0.77 GRM5 (0.30)
SCHEMBL1661148 0.74 MGLL (0.39) KMOHTR2CTAAR1CETP
SCHEMBL1661901 0.72 ABCG2 (0.43)
SCHEMBL9391575 0.69 CETP (0.50) HDAC4HDAC2HDAC8KMOHTR2C
SCHEMBL9390227 0.66 KCNH2 (0.48) HDAC4HDAC2HDAC8KMOHTR2C
SCHEMBL778529 0.64 HDAC4 (0.63) HDAC4HDAC2HDAC8KMOHTR2C
SCHEMBL7844832 0.64 HTR2C (0.72) HDAC4HDAC2HDAC8HTR2CDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed